Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

Abstract Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movem...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Per Odin, K. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/fe4c4bf3adf04393a2fc47c77e5e9245
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fe4c4bf3adf04393a2fc47c77e5e9245
record_format	dspace
spelling	oai:doaj.org-article:fe4c4bf3adf04393a2fc47c77e5e92452021-12-02T16:09:02ZViewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease10.1038/s41531-018-0051-72373-8057https://doaj.org/article/fe4c4bf3adf04393a2fc47c77e5e92452018-05-01T00:00:00Zhttps://doi.org/10.1038/s41531-018-0051-7https://doaj.org/toc/2373-8057Abstract Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.Per OdinK. Ray ChaudhuriJens VolkmannAngelo AntoniniAlexander StorchEspen DietrichsZvezdan PirtošekTove HenriksenMalcolm HorneDavid DevosFilip BergquistNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 4, Iss 1, Pp 1-7 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurology. Diseases of the nervous system RC346-429 Per Odin K. Ray Chaudhuri Jens Volkmann Angelo Antonini Alexander Storch Espen Dietrichs Zvezdan Pirtošek Tove Henriksen Malcolm Horne David Devos Filip Bergquist Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
description	Abstract Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality of life). Defining cutoffs by consensus, which can be subsequently tested and refined, is the first step to optimizing OM in the management of PD. OM should be used by all clinicians that treat people with PD but the least experienced may find the most value, but this requires guidance from experts to allow non-experts to apply guidelines. While evidence is gained for devices that produce OM, expert opinion is needed to supplement the evidence base.
format	article
author	Per Odin K. Ray Chaudhuri Jens Volkmann Angelo Antonini Alexander Storch Espen Dietrichs Zvezdan Pirtošek Tove Henriksen Malcolm Horne David Devos Filip Bergquist
author_facet	Per Odin K. Ray Chaudhuri Jens Volkmann Angelo Antonini Alexander Storch Espen Dietrichs Zvezdan Pirtošek Tove Henriksen Malcolm Horne David Devos Filip Bergquist
author_sort	Per Odin
title	Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
title_short	Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
title_full	Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
title_fullStr	Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
title_full_unstemmed	Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
title_sort	viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of parkinson’s disease
publisher	Nature Portfolio
publishDate	2018
url	https://doaj.org/article/fe4c4bf3adf04393a2fc47c77e5e9245
work_keys_str_mv	AT perodin viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT kraychaudhuri viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT jensvolkmann viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT angeloantonini viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT alexanderstorch viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT espendietrichs viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT zvezdanpirtosek viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT tovehenriksen viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT malcolmhorne viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT daviddevos viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease AT filipbergquist viewpointandpracticalrecommendationsfromamovementdisorderspecialistpanelonobjectivemeasurementintheclinicalmanagementofparkinsonsdisease
_version_	1718384509358964736

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease

Ejemplares similares